Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1Other 1

Conditions

Breast Neoplasms 23Prostatic Neoplasms 12Lung Neoplasms 12Colorectal Neoplasms 12Neoplasms 9Pancreatic Neoplasms 6Lymphoma 6Hematologic Neoplasms 6Uterine Cervical Neoplasms 5Ovarian Neoplasms 5Triple Negative Breast Neoplasms 4Neoplasm Metastasis 4Melanoma 4Hematopoietic and Lymphatic System Neoplasm 4Urinary Bladder Neoplasms 3Sarcoma 3Papillomavirus Infections 3Obesity-Related Malignant Neoplasm 3Obesity 3Motor Activity 3Endometrial Neoplasms 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Breast Carcinoma In Situ 3Anatomic Stage I Breast Cancer AJCC v8 3Vulvar Neoplasms 2Testicular Neoplasms 2Smoking Cessation 2Skin Carcinoma 2Rectal Neoplasms 2

Interventions

Standard of Care 1Spinal Cord Stimulation 1Specimen Handling 1Practice Guidelines as Topic 1Methods 1Massage 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1Cannabidiol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Chemotherapy-Induced Peripheral Neuropathy × Methods × 1 year × Clear all
NCT07365007 2026-03-03

A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment

University of Michigan Rogel Cancer Center

Phase NA Recruiting
50 enrolled
OtherOther solid neoplasm

Chemotherapy-Induced Peripheral Neuropathy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡